Biosig technologies confirms full compliance with nasdaq requirements for continued listing on the nasdaq capital market

Los angeles, ca, march 26, 2025 (globe newswire) -- biosig technologies, inc. (bsgm) (“biosig” or the “company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, is pleased to announce that its common stock will continue trading on the nasdaq capital market (“nasdaq”).
BSGM Ratings Summary
BSGM Quant Ranking